BSc3094

• CAT Number: I045256
• CAS Number: 946857-84-7
• Molecular Formula: C17H12N6O3S
• Molecular Weight: 380.38
• Purity: ≥95%
• Synonyms: N’-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]-3H-benzimidazole-5-carbohydrazide
• IUPAC Name: N'-[4-(4-nitrophenyl)-1,3-thiazol-2-yl]-3H-benzimidazole-5-carbohydrazide
• InChI: InChI=1S/C17H12N6O3S/c24-16(11-3-6-13-14(7-11)19-9-18-13)21-22-17-20-15(8-27-17)10-1-4-12(5-2-10)23(25)26/h1-9H,(H,18,19)(H,20,22)(H,21,24)
• InChIKey: VSMJKPUKWNIUBK-UHFFFAOYSA-N
• SMILES: C1=CC(=CC=C1C2=CSC(=N2)NNC(=O)C3=CC4=C(C=C3)N=CN4)[N+](=O)[O-]

BSc3094（Cat No.:I045256）is a small-molecule inhibitor designed to reduce amyloid-beta (Aβ) aggregation, a key pathological hallmark of Alzheimer’s disease and related neurodegenerative disorders. By binding to Aβ peptides, BSc3094 prevents their misfolding and fibril formation, thereby limiting plaque deposition and associated neurotoxicity. Preclinical studies suggest it can cross the blood–brain barrier, making it suitable for central nervous system targeting. BSc3094 is a valuable research tool for studying amyloid pathology, protein misfolding diseases, and therapeutic strategies aimed at modifying disease progression in Alzheimer’s and other amyloid-related neurodegenerative conditions.